Sex Differences in Familial Hypercholesterolemia

Sex differences in efficacy and safety of PCSK9 monoclonal antibodies: A real-world registry

(2023) Annette M.H. Galema-Boers et al.   ATHEROSCLEROSIS

LDL cholesterol targets rarely achieved in familial hypercholesterolemia patients: A sex and gender-specific analysis

(2023) M.M. Schreuder et al.   ATHEROSCLEROSIS

Familial hypercholesterolaemia in pregnancy: Australian case series and review

(2023) Mary Nangrahary et al.   AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY

International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia

(2023) Gerald F. Watts et al.   Nature Reviews Cardiology

Diagnosis, treatment and cardiovascular outcomes in homozygous familial hypercholesterolaemia: A sex-specific analysis

(2023) J. Mulder et al.   ATHEROSCLEROSIS

Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society

(2023) Jeanine E Roeters van Lennep et al.   EUROPEAN HEART JOURNAL

Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association

(2022) Connie W. Tsao et al.   CIRCULATION

Quality of life and coping in Dutch homozygous familial hypercholesterolemia patients: A qualitative study

(2022) Janneke W.C.M. Mulder et al.   ATHEROSCLEROSIS

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

(2022) Florian Kronenberg et al.   EUROPEAN HEART JOURNAL

Sex difference in circulating PCSK9 and its clinical implications

(2022) Fang Jia et al.   Frontiers in Pharmacology

Sex‐related differences in premature cardiovascular disease in familial hypercholesterolemia

(2022) Anandita Agarwala et al.   Journal of Clinical Lipidology

Sex differences in LDL-C response to PCSK9 inhibitors: A real world experience

(2022) Martine Paquette et al.   Journal of Clinical Lipidology

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

(2021) Antonio J. Vallejo-Vaz et al.   LANCET

Sex Differences in the Presentation, Treatment, and Outcome of Patients With Familial Hypercholesterolemia

(2021) Natalia Ryzhaya et al.   Journal of the American Heart Association

Loss of statin treatment years during pregnancy and breastfeeding periods in women with familial hypercholesterolemia

(2021) Marianne Klevmoen et al.   ATHEROSCLEROSIS

Worldwide Prevalence of Familial Hypercholesterolemia

(2020) Sabina O. Beheshti et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Sex-specific predictors of PCSK9 levels in a European population: The IMPROVE Study

(2020) Nicola Ferri et al.   ATHEROSCLEROSIS

Women Living with Familial Hypercholesterolemia: Challenges and Considerations Surrounding Their Care

(2020) Sujana Balla et al.   Current Atherosclerosis Reports

Sex differences in cardiovascular morbidity associated with familial hypercholesterolaemia: A retrospective cohort study of the UK Simon Broome register linked to national hospital records

(2020) Barbara Iyen et al.   ATHEROSCLEROSIS

Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry)

(2019) Meral Kayikcioglu et al.   Journal of Clinical Lipidology

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia

(2018) Liv J Mundal et al.   HEART

Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy

(2018) Annette M. Galema-Boers et al.   Journal of Clinical Lipidology

Sex differences in cholesterol levels from birth to 19 years of age may lead to increased cholesterol burden in females with FH

(2018) Kirsten B. Holven et al.   Journal of Clinical Lipidology

Impact of Lipids on Cardiovascular Health

(2018) Brian A. Ference et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

(2017) Brian A. Ference et al.   EUROPEAN HEART JOURNAL

Familial hypercholesterolemia in a European Mediterranean population—Prevalence and clinical data from 2.5 million primary care patients

(2017) Alberto Zamora et al.   Journal of Clinical Lipidology

Premature coronary heart disease and autosomal dominant hypercholesterolemia: Increased risk in women with LDLR mutations

(2016) Zahid Ahmad et al.   Journal of Clinical Lipidology

Lifelong Gender Gap in Risk of Incident Myocardial Infarction

(2016) Grethe Albrektsen et al.   JAMA Internal Medicine

Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death

(2015) Henriette Walaas Krogh et al.   EUROPEAN HEART JOURNAL

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

(2015)   LANCET

Long-Term Statin Treatment in Children with Familial Hypercholesterolemia: More Insight into Tolerability and Adherence

(2015) Marjet J. A. M. Braamskamp et al.   PEDIATRIC DRUGS

Daily life, experience and needs of persons suffering from homozygous familial hypercholesterolaemia: Insights from a patient survey

(2014) Eric Bruckert et al.   ATHEROSCLEROSIS SUPPLEMENTS

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

(2014) M. Cuchel et al.   EUROPEAN HEART JOURNAL

Predicting non-adherence in patients with familial hypercholesterolemia

(2014) J. M. H. Galema-Boers et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort

(2014) Matthew D Allard et al.   Lipids in Health and Disease

Inactivating Mutations in NPC1L1 and Protection from Coronary Heart Disease

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

Mortality Among Patients With Familial Hypercholesterolemia: A Registry‐Based Study in Norway, 1992–2010

(2014) Liv Mundal et al.   Journal of the American Heart Association

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

(2013) B. G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Cardiovascular disease prevention in women: A rapidly evolving scenario

(2012) S. Stranges et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Breastfeeding and Health Outcomes for the Mother-Infant Dyad

(2012) Christine M. Dieterich et al.   PEDIATRIC CLINICS OF NORTH AMERICA

Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia

(2011) Marit S. Nenseter et al.   ATHEROSCLEROSIS

A Longitudinal Study of Serum Lipoproteins in Relation to Endogenous Reproductive Hormones during the Menstrual Cycle: Findings from the BioCycle Study

(2010) Sunni L. Mumford et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Are Changes in Cardiovascular Disease Risk Factors in Midlife Women Due to Chronological Aging or to the Menopausal Transition?

(2009) Karen A. Matthews et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY